open access

Vol 24, No 2 (2017)
Letters to the Editor — Clinical cardiology
Published online: 2017-04-14
Get Citation

Determinants of improvement in six-minute walk distance from admission to discharge in acute systolic heart failure: Analysis from the ESCAPE trial

Hesham R. Omar, Maya Guglin
DOI: 10.5603/CJ.2017.0045
·
Pubmed: 28421593
·
Cardiol J 2017;24(2):227-230.

open access

Vol 24, No 2 (2017)
Letters to the Editor — Clinical cardiology
Published online: 2017-04-14

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Determinants of improvement in six-minute walk distance from admission to discharge in acute systolic heart failure: Analysis from the ESCAPE trial

Journal

Cardiology Journal

Issue

Vol 24, No 2 (2017)

Pages

227-230

Published online

2017-04-14

DOI

10.5603/CJ.2017.0045

Pubmed

28421593

Bibliographic record

Cardiol J 2017;24(2):227-230.

Authors

Hesham R. Omar
Maya Guglin

References (10)
  1. Fleg JL, Pina IL, Balady GJ, et al. Assessment of Functional Capacity in Clinical and Research Applications : An Advisory From the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation. 2000; 102(13): 1591–1597.
  2. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1): 111–117.
  3. Passantino A, Lagioia R, Mastropasqua F, et al. Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice. J Am Coll Cardiol. 2006; 48(1): 99–105.
  4. Abraham WT, Fisher WG, Smith AL, et al. MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002; 346(24): 1845–1853.
  5. Binanay C, Califf RM, Hasselblad V, et al. ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005; 294(13): 1625–1633.
  6. Shah MR, Hasselblad V, Stinnett SS, et al. Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes. J Card Fail. 2001; 7(2): 105–113.
  7. Gualeni A, D'Aloia A, Gentilini A, et al. Effects of maximally tolerated oral therapy on the six-minute walking test in patients with chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1998; 81(11): 1370–1372.
  8. Hutcheon SD, Gillespie ND, Crombie IK, et al. Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. Heart. 2002; 88(4): 373–377.
  9. Krum H, Sackner-Bernstein JD, Goldsmith RL, et al. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation. 1995; 92(6): 1499–1506.
  10. Packer M, Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation. 1996; 94(11): 2793–2799.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl